Pharmacological modulation in mesial temporal lobe epilepsy: Current status and future perspectives

Autor: Antonio Gambardella a, b, Angelo Labate a, Pierangelo Cifelli d, Gabriele Ruffolo c, Laura Mumoli a, Eleonora Aronica e, Eleonora Palma c, f

Publikováno v: Pharmacological research (Online) 113 (2016): 421–425. doi:10.1016/j.phrs.2016.09.019.
info:cnr-pdr/source/autori:Antonio Gambardella a,b, Angelo Labate a,b, Pierangelo Cifelli d, Gabriele Ruffolo c, Laura Mumoli a, Eleonora Aronica e, Eleonora Palma c,f/titolo:Pharmacological modulation in mesial temporal lobe epilepsy: Current status and future perspectives./doi:10.1016%2Fj.phrs.2016.09.019./rivista:Pharmacological research (Online)/anno:2016/pagina_da:421/pagina_a:425/intervallo_pagine:421–425/volume:113

Mesial temporal lobe epilepsy (MTLE) is frequently associated with hippocampal sclerosis (Hs), possibly caused by a primary brain injury that occurs a long time before the appearance of neurological symptoms. MTLE-Hs is, however, a heterogeneous cond

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::4d2a6f1dcb399c1fd4def48c2b5af77e
https://publications.cnr.it/doc/358682